Indies Pharma Jamaica Limited (JMSE:INDIES)

Market Cap	3.77B +13.2%
Revenue (ttm)	1.13B -2.8%
Net Income	181.29M -18.0%
EPS	0.14 -18.0%
Shares Out	1.33B
PE Ratio	20.80
Forward PE	n/a
Dividend	0.14 (4.75%)
Ex-Dividend Date	Mar 31, 2025

Volume	23,011
Average Volume	58,613
Open	n/a
Previous Close	2.830
Day's Range	2.690 - 2.830
52-Week Range	2.330 - 3.770
Beta	0.05
RSI	54.84
Earnings Date	Mar 13, 2026

About Indies Pharma Jamaica

Indies Pharma Jamaica Limited engages in the distribution and retail of pharmaceutical and auxiliary products in Jamaica. The company was incorporated in 2003 and is based in Montego Bay, Jamaica. Indies Pharma Jamaica Limited is a subsidiary of Bioprist Holdings Inc.

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2003
• Employees: 64
• Stock Exchange: Jamaica Stock Exchange
• Ticker Symbol: INDIES

Financial Performance

In fiscal year 2025, Indies Pharma Jamaica's revenue was 1.13 billion, a decrease of -2.82% compared to the previous year's 1.16 billion. Earnings were 181.29 million, a decrease of -18.04%.